KRAS Mutation as a Prognostic Factor in Ampullary Adenocarcinoma: A Meta-Analysis and Review

Oncotarget - United States
doi 10.18632/oncotarget.11156
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

P27Kip1 as a Prognostic Factor in Breast Cancer: A Systematic Review and Meta-Analysis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Transduodenal Ampullectomy for Ampullary Neoplasms - A Systematic Review and Meta-Analysis

HPB
HepatologyGastroenterology
2017English

P1.01-57 the Role of EGFR Mutation as a Prognostic Factor in Survival After Diagnosis of Brain Metastasis in NSCLC: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Transforming Growth Factor Beta 1 as a Prognostic Factor in Pulmonary Adenocarcinoma.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1994English

Integrated TCGA Analysis Implicates lncRNA CTB-193M12.5 as a Prognostic Factor in Lung Adenocarcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2018English

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Role of P53 as a Prognostic Factor for Survival in Lung Cancer: A Systematic Review of the Literature With a Meta-Analysis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

A Meta-Analysis of Prognostic Factor of Pancreatic Neuroendocrine Neoplasms

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy